These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diagnostic accuracy of whole-body diffusion-weighted magnetic resonance imaging with 3.0 T in detection of primary and metastatic neoplasms. Akay S, Kocaoglu M, Emer O, Battal B, Arslan N. J Med Imaging Radiat Oncol; 2013 Jun; 57(3):274-82. PubMed ID: 23721135 [Abstract] [Full Text] [Related]
3. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer. Sakurai Y, Kawai H, Iwano S, Ito S, Ogawa H, Naganawa S. J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138 [Abstract] [Full Text] [Related]
12. Role of combined DWIBS/3D-CE-T1w whole-body MRI in tumor staging: Comparison with PET-CT. Manenti G, Cicciò C, Squillaci E, Strigari L, Calabria F, Danieli R, Schillaci O, Simonetti G. Eur J Radiol; 2012 Aug; 81(8):1917-25. PubMed ID: 21908120 [Abstract] [Full Text] [Related]
13. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography. Sommer G, Wiese M, Winter L, Lenz C, Klarhöfer M, Forrer F, Lardinois D, Bremerich J. Eur Radiol; 2012 Dec; 22(12):2859-67. PubMed ID: 22772365 [Abstract] [Full Text] [Related]
14. Assessment of naive indolent lymphoma using whole-body diffusion-weighted imaging and T2-weighted MRI: results of a prospective study in 30 patients. Hong GS, Chae EJ, Ryu JS, Chae SY, Lee HS, Yoon DH, Suh C. Cancer Imaging; 2021 Jan 07; 21(1):5. PubMed ID: 33413685 [Abstract] [Full Text] [Related]
15. Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients. Abdulqadhr G, Molin D, Aström G, Suurküla M, Johansson L, Hagberg H, Ahlström H. Acta Radiol; 2011 Mar 01; 52(2):173-80. PubMed ID: 21498346 [Abstract] [Full Text] [Related]
16. Whole-body MRI, including diffusion-weighted imaging, for staging lymphoma: comparison with CT in a prospective multicenter study. Kwee TC, Vermoolen MA, Akkerman EA, Kersten MJ, Fijnheer R, Ludwig I, Beek FJ, van Leeuwen MS, Bierings MB, Bruin MC, Zsíros J, Quarles van Ufford HM, de Klerk JM, Adam J, Stoker J, Uiterwaal CS, Nievelstein RA. J Magn Reson Imaging; 2014 Jul 01; 40(1):26-36. PubMed ID: 24307538 [Abstract] [Full Text] [Related]
17. Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer. Pauls S, Schmidt SA, Juchems MS, Klass O, Luster M, Reske SN, Brambs HJ, Feuerlein S. Eur J Radiol; 2012 Jan 01; 81(1):178-82. PubMed ID: 20932700 [Abstract] [Full Text] [Related]
18. FDG PET/MR for the assessment of lymph node involvement in lymphoma: initial results and role of diffusion-weighted MR. Platzek I, Beuthien-Baumann B, Ordemann R, Maus J, Schramm G, Kitzler HH, Laniado M, Kotzerke J, van den Hoff J. Acad Radiol; 2014 Oct 01; 21(10):1314-9. PubMed ID: 25086953 [Abstract] [Full Text] [Related]
19. Molecular imaging of malignant tumor metabolism: whole-body image fusion of DWI/CT vs. PET/CT. Reiner CS, Fischer MA, Hany T, Stolzmann P, Nanz D, Donati OF, Weishaupt D, von Schulthess GK, Scheffel H. Acad Radiol; 2011 Aug 01; 18(8):940-6. PubMed ID: 21718953 [Abstract] [Full Text] [Related]